Achieve Life Sciences, Inc. (ACHV) Free cash flow 2016–2025
Achieve Life Sciences, Inc. (ACHV) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$49.5MFY2025 · since FY2016: -$248,000 → -$49.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.5M | — |
| FY2023 | -$24.5M | — |
| FY2020 | -$13.5M | +11.6% |
| FY2019 | -$15.3M | -43.1% |
| FY2018 | -$10.7M | — |
| FY2016 | -$248,000 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ACHV financial trends
ACHV RevenueACHV Net incomeACHV Net marginACHV Gross profitACHV Gross marginACHV Operating incomeACHV Operating marginACHV Operating cash flowACHV Capital expendituresACHV Return on equityACHV Stock buybacksACHV Dividends paidACHV Total assetsACHV Total liabilitiesACHV Shareholders’ equityACHV overview →